CY1114960T1 - Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου - Google Patents

Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου

Info

Publication number
CY1114960T1
CY1114960T1 CY20141100195T CY141100195T CY1114960T1 CY 1114960 T1 CY1114960 T1 CY 1114960T1 CY 20141100195 T CY20141100195 T CY 20141100195T CY 141100195 T CY141100195 T CY 141100195T CY 1114960 T1 CY1114960 T1 CY 1114960T1
Authority
CY
Cyprus
Prior art keywords
tramadoli
sellekoxibe
compositions including
pain treatment
treatment
Prior art date
Application number
CY20141100195T
Other languages
English (en)
Inventor
Salido Enrique Portillo
CES Sebastià VIDELA
Original Assignee
Laboratorios Del Dr. Esteve, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41566149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1114960(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Del Dr. Esteve, S.A. filed Critical Laboratorios Del Dr. Esteve, S.A.
Publication of CY1114960T1 publication Critical patent/CY1114960T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Η παρούσα εφεύρεση αφορά σε φαρμακευτικές συνθέσεις που περιλαμβάνουν τραμαδόλη και σελεκοξίμπη και χρήσεις αυτών ως φάρμακα ή αναλγητικά, ειδικότερα για την θεραπεία σοβαρού έως μετρίου πόνου με φλεγμονώδες συστατικό.
CY20141100195T 2009-10-16 2014-03-10 Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου CY1114960T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09384004A EP2311446A1 (en) 2009-10-16 2009-10-16 Compositions comprising Tramadol and Celecoxib in the treatment of pain
EP10765762.9A EP2488170B1 (en) 2009-10-16 2010-10-15 Compositions comprising tramadol and celecoxib in the treatment of pain

Publications (1)

Publication Number Publication Date
CY1114960T1 true CY1114960T1 (el) 2016-12-14

Family

ID=41566149

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100195T CY1114960T1 (el) 2009-10-16 2014-03-10 Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου

Country Status (34)

Country Link
US (3) US8569271B2 (el)
EP (3) EP2311446A1 (el)
JP (2) JP5579858B2 (el)
KR (1) KR101688996B1 (el)
CN (2) CN102573824A (el)
AR (1) AR078653A1 (el)
AU (1) AU2010306114B2 (el)
BR (1) BR112012005044B8 (el)
CA (1) CA2771651C (el)
CO (1) CO6511249A2 (el)
CY (1) CY1114960T1 (el)
DK (1) DK2488170T3 (el)
EC (1) ECSP12011735A (el)
ES (1) ES2450615T3 (el)
HK (1) HK1173379A1 (el)
HR (1) HRP20140157T1 (el)
IL (1) IL218096A (el)
IN (1) IN2012DN01434A (el)
MA (1) MA33743B1 (el)
MX (1) MX2012003051A (el)
MY (1) MY156275A (el)
NZ (1) NZ598361A (el)
PL (1) PL2488170T3 (el)
PT (1) PT2488170E (el)
RS (1) RS53202B (el)
RU (2) RU2707752C2 (el)
SG (1) SG178833A1 (el)
SI (1) SI2488170T1 (el)
SM (1) SMT201400035B (el)
TN (1) TN2012000059A1 (el)
TW (1) TWI466668B (el)
UA (1) UA108213C2 (el)
WO (1) WO2011045075A1 (el)
ZA (1) ZA201202151B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2177215A1 (en) 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of tramadol and NSAIDs
US8746719B2 (en) 2010-08-03 2014-06-10 Polaris Industries Inc. Side-by-side vehicle
MX346312B (es) * 2011-04-05 2017-03-15 Optosolve Res & Dev Ltd Tratamientos oftalmicos.
US9173863B2 (en) 2012-02-06 2015-11-03 Innovative Med Concepts, LLC Antiviral compound and COX-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib
WO2016116942A1 (en) 2015-01-20 2016-07-28 Anlon Chemical Research Organization Novel pharmaceutical compounds comprising ticagrelor with salts of aspirin
WO2016191744A1 (en) * 2015-05-28 2016-12-01 Dr. Reddy's Laboratories Ltd. Oral composition of celecoxib for treatment of pain
KR101710792B1 (ko) * 2015-07-14 2017-02-28 주식회사 유영제약 세레콕시브 및 트라마돌을 함유하는 약제학적 조성물
MX2016006464A (es) * 2016-05-18 2017-11-17 Laboratorios Liomont S A De C V Composicion farmaceutica de una combinacion de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor.
RU2745196C2 (ru) * 2016-05-27 2021-03-22 Др. Редди'С Лабораторис Лтд. Пероральная композиция целекоксиба для лечения боли
US20200323780A1 (en) * 2017-04-03 2020-10-15 Kims Healthcare Co., Ltd. Bilayer combination tablet for oral administration containing tramadol and celecoxib
WO2018186650A2 (ko) * 2017-04-03 2018-10-11 주식회사 킴스헬스케어 트라마돌과 셀레콕시브를 포함한 경구투여용 이중 복합정제
KR102631399B1 (ko) 2018-03-30 2024-02-01 씨지인바이츠 주식회사 폴마콕시브 및 프레가발린을 포함하는 통증 치료용 약제학적 조성물
KR20220008301A (ko) * 2019-05-14 2022-01-20 에스테베 파마슈티칼스 에스에이 트라마돌의 남용 경향을 감소시키면서 통증을 치료하기 위한 트라마돌과 세레콕시브의 공-결정의 용도
CN112007024A (zh) * 2019-05-28 2020-12-01 江苏恒瑞医药股份有限公司 艾瑞昔布与曲马多联合在制备治疗疼痛的药物中的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516803A (en) 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
AU661723B2 (en) 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
JP2002538176A (ja) * 1999-03-01 2002-11-12 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド トラマドール物質および選択的ｃｏｘ−２阻害薬を含んで成る組成物
DE19927688A1 (de) 1999-06-17 2000-12-21 Gruenenthal Gmbh Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
AU2003208485B2 (en) * 2002-02-19 2009-05-28 Adcock Ingram Limited Pharmaceutical combinations of COX-2 inhibitors and opiates
US20080031950A1 (en) * 2007-04-27 2008-02-07 Nectid Inc. Novel anelgesic combination
CA2771665C (en) 2009-10-16 2015-10-06 Laboratorios Del Dr. Esteve, S.A. Co-crystals of tramadol and coxibs
EP2392319A1 (en) 2010-06-04 2011-12-07 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical compositions of co-crystals of tramadol and coxibs

Also Published As

Publication number Publication date
EP2737898A1 (en) 2014-06-04
BR112012005044B8 (pt) 2021-05-25
UA108213C2 (uk) 2015-04-10
HK1173379A1 (en) 2013-05-16
SI2488170T1 (sl) 2014-04-30
RU2016125895A3 (el) 2018-12-05
SG178833A1 (en) 2012-05-30
PL2488170T3 (pl) 2014-05-30
BR112012005044B1 (pt) 2020-12-15
KR101688996B1 (ko) 2016-12-22
EP2311446A1 (en) 2011-04-20
AR078653A1 (es) 2011-11-23
TW201114418A (en) 2011-05-01
US8569271B2 (en) 2013-10-29
EP2488170B1 (en) 2014-01-22
CN107050006A (zh) 2017-08-18
RU2707752C2 (ru) 2019-11-29
CA2771651C (en) 2016-08-23
AU2010306114B2 (en) 2015-07-23
BR112012005044A2 (pt) 2016-05-03
WO2011045075A1 (en) 2011-04-21
DK2488170T3 (en) 2014-03-03
MA33743B1 (fr) 2012-11-01
MY156275A (en) 2016-01-29
ZA201202151B (en) 2012-11-28
ES2450615T3 (es) 2014-03-25
MX2012003051A (es) 2012-05-29
CO6511249A2 (es) 2012-08-31
SMT201400035B (it) 2014-05-07
IL218096A0 (en) 2012-04-30
US20140024622A1 (en) 2014-01-23
JP2013507408A (ja) 2013-03-04
ECSP12011735A (es) 2012-05-30
JP2014221797A (ja) 2014-11-27
HRP20140157T1 (hr) 2014-03-28
EP2488170A1 (en) 2012-08-22
US20120172341A1 (en) 2012-07-05
KR20120089287A (ko) 2012-08-09
TN2012000059A1 (en) 2013-09-19
RU2012120087A (ru) 2013-11-27
CN102573824A (zh) 2012-07-11
JP5579858B2 (ja) 2014-08-27
IL218096A (en) 2015-02-26
IN2012DN01434A (el) 2015-06-05
AU2010306114A1 (en) 2012-03-15
PT2488170E (pt) 2014-03-11
RS53202B (en) 2014-06-30
CA2771651A1 (en) 2011-04-11
RU2016125895A (ru) 2018-12-05
TWI466668B (zh) 2015-01-01
US20150150889A1 (en) 2015-06-04
NZ598361A (en) 2014-01-31

Similar Documents

Publication Publication Date Title
CY1114960T1 (el) Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
CY1118680T1 (el) Φαρμακευτικη συνθεση
CY1122480T1 (el) Μεθυλικη βαρδοξολονη για τη θεραπεια παχυσαρκιας
CY1124307T1 (el) Φαρμακευτικη συνθεση, μεθοδοι θεραπειας και χρησεις αυτων
CY1119660T1 (el) Antibakthpiakh απο toy στοματος συνθεση
CY1119596T1 (el) Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
EA201170832A1 (ru) Пуриновые соединения
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
CY1120557T1 (el) Μορια δεσμευσης anti-pseudomonas psl και χρησεις αυτων
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
EA201200617A1 (ru) Полимеры на основе циклодекстрина для доставки лекарственных средств
BRPI0917017B8 (pt) inibidores de pirrol de s-nitrosoglutationa redutase como agentes terapêuticos
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
BR112014021531A2 (pt) composto, composição farmacêutica e usos dos mesmos
MX2010003299A (es) Oligonucleotidos muy cortos (micromirs).
CR20120202A (es) Métodos y composiciones para tratar cáncer
BR112012016853A2 (pt) "composições farmacêuticas para administração oral de peptídeos de insulina".
CY1123490T1 (el) Συνθεσεις που προερχονται απο χιτοζανη
BR112014027981A2 (pt) compostos do tipo fumagilol e métodos de produção e utilização dos mesmos
CY1117785T1 (el) Αναστολεας φωσφοϊνοσιτιδιου 3-κινασης με ενα τμημα δεσμευσης ψευδαργυρου
CY1122998T1 (el) Μεθοδοι και συνθεσεις για την αντιμετωπιση της καταθλιψης χρησιμοποιωντας κυκλοβενζαπρινη
CL2012003322A1 (es) Compuestos derivados de benzamida sustituidas; composicion farmacéutica; y uso en el tratamiento del cancer.
TR201910866T4 (tr) Kanser tedavisi için birleşik preparasyonlar.